| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Cleo Whiting, Xuejing Duan, Adam Friedma. Evaluation of Cannabis and Cannabinoid Product Use, Knowledge, and Attitudes in the Eczema Community. Journal of drugs in dermatology : JDD. vol 21. issue 4. 2022-04-07. PMID:35389585. |
evaluation of cannabis and cannabinoid product use, knowledge, and attitudes in the eczema community. |
2022-04-07 |
2023-08-13 |
Not clear |
| Tameika R James, Andrea A Richards, Dwight A Lowe, Walton A Reid, Charah T Watson, Dagogo J Peppl. The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity. Journal of cannabis research. vol 4. issue 1. 2022-04-06. PMID:35382895. |
the main biological activities of cannabis are due to the presence of several compounds known as cannabinoids. |
2022-04-06 |
2023-08-13 |
Not clear |
| Tameika R James, Andrea A Richards, Dwight A Lowe, Walton A Reid, Charah T Watson, Dagogo J Peppl. The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity. Journal of cannabis research. vol 4. issue 1. 2022-04-06. PMID:35382895. |
delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) are two of the main cannabinoids. |
2022-04-06 |
2023-08-13 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis. Archives of public health = Archives belges de sante publique. vol 80. issue 1. 2022-03-31. PMID:35354487. |
geotemporospatial and causal inferential epidemiological overview and survey of usa cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis. |
2022-03-31 |
2023-08-13 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions. Archives of public health = Archives belges de sante publique. vol 80. issue 1. 2022-03-31. PMID:35354495. |
geotemporospatial and causal inferential epidemiological overview and survey of usa cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions. |
2022-03-31 |
2023-08-13 |
Not clear |
| Albert Stuart Reece, Gary Kenneth Huls. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers. Archives of public health = Archives belges de sante publique. vol 80. issue 1. 2022-03-31. PMID:35354499. |
geotemporospatial and causal inferential epidemiological overview and survey of usa cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers. |
2022-03-31 |
2023-08-13 |
Not clear |
| Liliana Soroceanu, Eric Singer, Pratiksha Dighe, Max Sidorov, Chandani Limbad, Aida Rodriquez-Brotons, Peter Rix, Rinette W L Woo, Lawrence Dickinson, Pierre-Yves Desprez, Sean D McAlliste. Cannabidiol inhibits RAD51 and sensitizes glioblastoma to temozolomide in multiple orthotopic tumor models. Neuro-oncology advances. vol 4. issue 1. 2022-03-31. PMID:35356807. |
cannabidiol (cbd), a nonpsychoactive cannabinoid with a low toxicity profile, has been shown to produce antitumor activity across cancers in part through selective production of reactive oxygen species (ros) in tumor cells. |
2022-03-31 |
2023-08-13 |
Not clear |
| b' Nera \\xc5\\xbdigi\\xc4\\x87, Mevludin Hasanovi\\xc4\\x87, Izet Pajevi\\xc4\\x87, Miro Jakovljevi\\xc4\\x8. Possible Consequences of Cannabis Legalization - What Do Research Show? Psychiatria Danubina. vol 33. issue Suppl 4. 2022-03-30. PMID:35354186.' |
acute and chronic cannabis use has been shown to be detrimental to several aspects of psychological and physical health and many experimental studies done on healthy people indicate the potential of Δ9- tetra hydro cannabinoid (thc) in inducing transient, dose-dependent psychotic symptoms, but also affective, behavioral, cognitive, neurovegetative, and psychophysical symptoms. |
2022-03-30 |
2023-08-13 |
Not clear |
| b' Izet Pajevi\\xc4\\x87, Mevludin Hasanovi\\xc4\\x87, Nera \\xc5\\xbdigi\\xc4\\x87, Ahmed Pajevi\\xc4\\x87, Leila Avdi\\xc4\\x8. Do Cannabis and Cannabinoids Have a Psychopharmacotherapeutic Effect? Psychiatria Danubina. vol 33. issue Suppl 4. 2022-03-30. PMID:35354187.' |
do cannabis and cannabinoids have a psychopharmacotherapeutic effect? |
2022-03-30 |
2023-08-13 |
Not clear |
| Amanda H X Lee, Emmanuel K Tse, Thomas E Nightingale, Rahul Sachdeva, Matthias Walter, Andrei V Krassiouko. Cannabis health survey on usage in women with spinal cord injury and knowledge among physicians: A cross-sectional study. The journal of spinal cord medicine. 2022-03-29. PMID:35349394. |
moreover, due to the lack of current evidence for cannabis, it is important to characterize the perceptions and knowledge of physicians towards both recreational and synthetic cannabinoids. |
2022-03-29 |
2023-08-13 |
Not clear |
| Briana Hempel, Zheng-Xiong X. Receptor mechanisms underlying the CNS effects of cannabinoids: CB Advances in pharmacology (San Diego, Calif.). vol 93. 2022-03-28. PMID:35341569. |
receptor mechanisms underlying the cns effects of cannabinoids: cb cannabis legalization continues to progress in many us states and other countries. |
2022-03-28 |
2023-08-13 |
Not clear |
| Victor Longoria, Hannah Parcel, Bameelia Toma, Annu Minhas, Rana Zein. Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination. Biomedicines. vol 10. issue 3. 2022-03-25. PMID:35327341. |
neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination. |
2022-03-25 |
2023-08-13 |
Not clear |
| Petr Jirasek, Alexandr Jusku, Vilim Simanek, Jana Frankova, Jan Storch, Jan Vace. Cannabidiol and periodontal inflammatory disease: A critical assessment. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2022-03-25. PMID:35332345. |
cannabidiol (cbd), a non-psychotropic cannabinoid produced by the genus cannabis, is a phytoceutical that activates the endocannabinoid system (ecs) through binding to cb1 and cb2 receptors. |
2022-03-25 |
2023-08-13 |
Not clear |
| Liguo Song, Shelby Carlson, Gabrielle Valenzuela, Madison Chao, Shashi Bhushan Pathipak. Development of a validated method for rapid quantification of up to sixteen cannabinoids using ultra-high-performance liquid chromatography diode-array detector with optional electrospray ionization time-of-flight mass spectrometry detection. Journal of chromatography. A. vol 1670. 2022-03-25. PMID:35334372. |
due to the recent legalization of medical and recreational cannabis in many countries in the world, there has been an increasing demand for accurate quantification of a growing number of cannabinoids. |
2022-03-25 |
2023-08-13 |
Not clear |
| Deepak Cyril D'Souza, Marta DiForti, Suhas Ganesh, Tony P George, Wayne Hall, Carsten Hjorthøj, Oliver Howes, Matcheri Keshavan, Robin M Murray, Timothy B Nguyen, Godfrey D Pearlson, Mohini Ranganathan, Alex Selloni, Nadia Solowij, Edoardo Spinazzol. Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2022-03-22. PMID:35315315. |
consensus paper of the wfsbp task force on cannabis, cannabinoids and psychosis. |
2022-03-22 |
2023-08-13 |
Not clear |
| Sarah Lord, Janet Hardy, Phillip Goo. Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer? Current treatment options in oncology. 2022-03-22. PMID:35316478. |
focus has fallen on cannabidiol (cbd) as a potential treatment for a variety of symptoms in advanced cancer due to the lack of psychoactive side effects and the potential molecular mechanisms of action associated with this cannabinoid. |
2022-03-22 |
2023-08-13 |
Not clear |
| Guillermo Burillo-Putze, John R Richards, Consuelo Rodríguez-Jiménez, Alejandro Sanchez-Agüer. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature. Expert opinion on pharmacotherapy. 2022-03-21. PMID:35311429. |
cannabinoid hyperemesis syndrome (chs) is an uncommon but unique disorder defined by recurrent abdominal pain, intractable nausea, and emesis in patients who regularly smoke cannabis. |
2022-03-21 |
2023-08-13 |
Not clear |
| Katherine Walukevich-Dienst, Paige E Morris, Raymond P Tucker, Amy L Copeland, Julia D Buckne. Development and initial psychometric properties of the Cannabidiol Outcome Expectancies Questionnaire (CBD-OEQ). Psychological assessment. 2022-03-17. PMID:35298216. |
cannabidiol (cbd), a nonpsychoactive cannabinoid, is used by many individuals to treat medical and mental health conditions, despite limited support for the efficacy of cbd for these conditions. |
2022-03-17 |
2023-08-13 |
Not clear |
| Escarlin Perez, Jasmin Ceja-Vega, Michael Krmic, Alondra Gamez Hernandez, Jamie Gudyka, Riley Porteus, Sunghee Le. Differential Interaction of Cannabidiol with Biomembranes Dependent on Cholesterol Concentration. ACS chemical neuroscience. 2022-03-17. PMID:35298887. |
cannabidiol (cbd), the major nonpsychoactive component of plant-derived cannabinoids, has been reported to have a broad range of potential beneficial pharmacological effects on the central nervous system (cns). |
2022-03-17 |
2023-08-13 |
Not clear |
| Jami D Reber, Erin L Karschner, Joshua Z Seither, Jessica L Knittel, Katherine V Dozier, Jeffrey P Walterschei. An Enhanced LC-MS/MS Technique for Distinguishing Δ8- and Δ9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens. Journal of analytical toxicology. 2022-03-10. PMID:35265983. |
among the abundance of cannabinoids identified in cannabis, the active parent drug, Δ9-tetrahydrocannabinol (Δ9-thc), and its oxidized metabolite, 11-nor-9-carboxy-Δ9-thc (Δ9-thccooh), are attractive analytical targets to detect cannabis use. |
2022-03-10 |
2023-08-13 |
Not clear |